Krakaris Emmanuel's Form 4 filing
Augmedix, Inc. (AUGX) · filed May 17, 2024
- Accession no.
- 0001213900-24-044877
- Filed
- May 17, 2024
- Trade date
- May 15, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.20K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Krakaris EmmanuelCIK 0001826616 | Director, Officer (PRESIDENT, CEO, AND SECRETARY) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2024 | Common Stock | MOption exerciseAcquired | +9,375 | –F1 | – | 62,426 | Direct | |
| May 15, 2024 | Common Stock | SSaleDisposed | −3,528 | $1.19 | −$4,198.32 | 58,898 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2024 | Common Stock | MOption exerciseDisposed | −9,375 | $0.00 | $0 | 140,625 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.
Referenced by the price of 1 transaction in Table I.